Pharmaceutical Sales 2009

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2009, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2009 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2008
1 Lipitor Pfizer Inc 5,363,193 -8.8%
2 Nexium AstraZeneca Pharmaceuticals, LP 5,014,827 4.6%
3 Plavix Bristol-Myers Squibb Company 4,223,124 11.2%
4 Advair Diskus GlaxoSmithKline 3,653,410 2.3%
5 (1) Seroquel AstraZeneca Pharmaceuticals, LP 3,117,591 7.2%
6 (6) Abilify Bristol-Myers Squibb Company 3,083,351 30.0%
7 Singulair Merck & Co., Inc. 3,027,378 4.5%
8 (1) OxyContin Purdue Pharma LP 3,020,239 20.7%
9 (1) Actos Takeda Pharmaceuticals U.S.A., Inc 2,531,621 3.4%
10 (5) Prevacid Takeda Pharmaceuticals U.S.A., Inc 2,508,555 -23.9%
11 (3) Cymbalta Eli Lilly and Company 2,404,353 10.8%
12 (4) Effexor XR Pfizer Inc 2,385,507 -10.2%
13 (2) Lexapro Forest Pharmaceuticals, Inc 2,334,422 -3.2%
14 (3) Crestor AstraZeneca Pharmaceuticals, LP 2,308,138 37.7%
15 Zyprexa Eli Lilly and Company 1,855,436 6.1%
16 Valtrex GlaxoSmithKline 1,754,727 4.2%
17 (10) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 1,556,273 25.8%
18 (3) Lantus Sanofi (formerly Sanofi Aventis) 1,512,403 2.5%
19 (5) Lyrica Pfizer Inc 1,445,445 4.0%
20 Celebrex Pfizer Inc 1,437,539 -5.8%
21 (1) Levaquin Janssen Pharmaceuticals, Inc 1,373,131 -6.0%
22 (9) Aricept Eisai Corporation 1,347,293 17.2%
23 (9) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 1,338,252 17.1%
24 (1) Diovan Novartis Corporation 1,328,515 3.5%
25 (4) Diovan HCT Novartis Corporation 1,244,245 2.6%
26 Tricor Abbott Laboratories 1,224,894 -2.0%
27 (6) Concerta Johnson & Johnson 1,180,887 7.0%
28 (13) Januvia Merck & Co., Inc. 1,145,933 25.4%
29 (11) Vytorin Merck & Co., Inc. 1,133,438 -26.7%
30 (7) Adderall XR Shire US Inc 1,130,274 -21.9%
31 (9) Lovenox Sanofi (formerly Sanofi Aventis) 1,075,620 17.7%
32 (7) Atripla Gilead Sciences, Inc. 1,064,056 16.2%
33 (3) Zetia Merck & Co., Inc. 1,025,238 -13.4%
34 Aciphex Eisai Corporation 996,052 -5.3%
35 (8) Ambien CR Sanofi (formerly Sanofi Aventis) 983,296 13.6%
36 (2) Viagra Pfizer Inc 974,727 5.9%
37 (24) Topamax Janssen Pharmaceuticals, Inc 939,312 -55.9%
38 (2) Lidoderm Endo Pharmaceuticals 937,263 -3.4%
39 (33) ProAir HFA Teva Pharmaceuticals 935,532 77.3%
40 () NovoLog Novo Nordisk Inc. 905,235 26.6%
41 (29) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 894,208 68.1%
42 Nasonex Merck & Co., Inc. 893,579 -1.2%
43 (1) Provigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 883,339 4.4%
44 (1) Geodon Oral Pfizer Inc 873,952 9.6%
45 (1) Truvada Gilead Sciences, Inc. 862,711 11.2%
46 (1) Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 813,087 5.5%
47 (4) Humalog Eli Lilly and Company 757,108 7.7%
48 (8) Niaspan Abbott Laboratories 716,589 12.2%
49 (3) Detrol LA Pfizer Inc 711,749 2.1%
50 (11) Yaz Bayer Healthcare Pharmaceuticals 701,540 19.8%
51 (3) Cozaar Merck & Co., Inc. 697,815 1.1%
52 (11) Namenda Forest Pharmaceuticals, Inc 670,226 15.1%
53 (43) Vyvanse Shire US Inc 660,109 76.0%
54 (68) Tamiflu Genentech, Inc (member of Roche group) 651,444 136.8%
55 (11) Cialis Eli Lilly and Company 650,494 17.2%
56 (8) Arimidex AstraZeneca Pharmaceuticals, LP 640,326 12.6%
57 (9) Enbrel Amgen Inc. 638,695 -16.4%
58 (9) Flovent HFA GlaxoSmithKline 621,041 12.3%
59 (52) Lantus SoloStar Sanofi (formerly Sanofi Aventis) 610,161 93.1%
60 (5) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 608,121 8.9%
61 (6) Pulmicort Respules AstraZeneca Pharmaceuticals, LP 607,397 -6.7%
62 (2) Byetta Amylin Pharmaceuticals, Inc. 554,861 -6.7%
63 (11) Benicar HCT Daiichi Sankyo 553,640 7.5%
64 (24) AndroGel Abbott Laboratories 546,994 24.0%
65 (3) Prograf Astellas Pharma US 541,151 -7.4%
66 (5) Hyzaar Merck & Co., Inc. 539,827 2.2%
67 (19) Benicar Daiichi Sankyo 526,569 15.6%
68 (1) Premarin tabs Wyeth 520,151 -5.2%
69 (18) Gleevec Novartis Corporation 519,508 15.3%
70 (3) Reyataz Bristol-Myers Squibb Company 519,018 -0.1%
71 (6) Boniva Genentech, Inc (member of Roche group) 511,277 -0.2%
72 (6) Strattera Eli Lilly and Company 511,187 -0.1%
73 (54) Lamictal GlaxoSmithKline 498,599 -67.6%
74 (1) Synthroid Abbott Laboratories 495,523 -3.8%
75 (7) Asacol Procter & Gamble 491,311 5.9%
76 (63) Symbicort AstraZeneca Pharmaceuticals, LP 487,690 105.0%
77 (8) Humira Pen Abbott Laboratories 487,601 27.8%
78 (32) Solodyn Medicis Pharmaceutical Corporation 479,365 51.7%
79 (31) Enbrel Sureclick Amgen Inc. 479,132 10.5%
80 (22) Chantix Pfizer Inc 472,207 -22.0%
81 (1) Skelaxin Elan Corporation 472,083 -5.8%
82 (32) CellCept Roche Pharmaceuticals 468,229 -34.2%
83 (2) Evista Eli Lilly and Company 466,955 -6.6%
84 (16) Protonix Wyeth 461,079 -16.6%
85 (1) Xalatan Pfizer Inc 457,121 0.2%
86 (37) Actonel Procter & Gamble 435,977 -39.0%
87 (12) Copaxone Sanofi (formerly Sanofi Aventis) 428,384 15.6%
88 (13) Femara Novartis Corporation 427,132 18.3%
89 (19) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc 417,934 24.6%
90 (10) Avodart GlaxoSmithKline 416,285 14.1%
91 (15) Avandia GlaxoSmithKline 407,906 -20.6%
92 (7) Humira Abbott Laboratories 402,654 -11.7%
93 (13) NovoLog Mix 70/30 Novo Nordisk Inc. 400,683 15.4%
94 Avapro Bristol-Myers Squibb Company 398,768 -1.7%
95 (12) Restasis Allergan, Inc 398,143 17.4%
96 (31) Levemir Novo Nordisk Inc. 394,246 53.9%
97 (7) Avelox Bayer Healthcare Pharmaceuticals 388,933 -9.3%
98 (17) Vesicare Astellas Pharma US 379,283 26.8%
99 (41) Janumet Merck & Co., Inc. 378,837 59.6%
100 (4) Sensipar Amgen Inc. 369,011 5.9%
101 (4) Aldara Medicis Pharmaceutical Corporation 366,825 5.5%
102 (4) Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 356,898 -4.1%
103 () Seroquel XR AstraZeneca Pharmaceuticals, LP 356,402 151.8%
104 (9) Focalin XR Novartis Corporation 352,024 13.6%
105 (12) RenaGel Genzyme Corporation 351,383 -14.0%
106 (4) Avalide Bristol-Myers Squibb Company 350,462 -1.5%
107 (70) Keppra UCB Inc. 339,978 -63.9%
108 (6) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc 338,930 12.5%
109 () Caduet Pfizer Inc 331,382 -15.0%
110 () Lotrel Novartis Corporation 323,873 -12.0%
111 (13) NuvaRing Merck & Co., Inc. 318,518 19.2%
112 Norvir Abbott Laboratories 311,949 0.2%
113 (16) Kaletra Abbott Laboratories 309,015 -17.2%
114 () Ventolin HFA GlaxoSmithKline 297,759 285.3%
115 (62) Isentress Merck & Co., Inc. 286,333 63.2%
116 (16) Invega Janssen Pharmaceuticals, Inc 280,698 14.1%
117 () Prevacid SoluTab Takeda Pharmaceuticals U.S.A., Inc 276,710 NA
118 (11) Risperdal Consta Janssen Pharmaceuticals, Inc 274,523 9.4%
119 (66) Depakote ER Abbott Laboratories 272,177 -60.7%
120 (3) Avonex Biogen Idec 271,515 -0.7%
121 (70) Doryx Pfizer Inc 268,774 69.6%
122 (36) Loestrin 24 Fe Teva Pharmaceuticals 267,190 33.4%
123 (7) Forteo Eli Lilly and Company 266,923 -8.5%
124 () Pristiq Wyeth 266,654 397.5%
125 (1) Epzicom GlaxoSmithKline 260,282 -1.9%
126 (6) Tarceva Genentech, Inc (member of Roche group) 257,591 -7.0%
127 (16) Proventil HFA Merck & Co., Inc. 257,440 13.0%
128 () Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc 256,362 4.2%
129 (9) Lumigan Allergan, Inc 255,177 7.0%
130 (5) Coreg CR GlaxoSmithKline 253,377 -4.7%
131 (14) Allegra-D 12 Hour Sanofi (formerly Sanofi Aventis) 252,670 -12.3%
132 (22) Welchol Daiichi Sankyo 252,474 20.6%
133 (2) Levitra Bayer Healthcare Pharmaceuticals 252,148 5.1%
134 Kadian Actavis 250,497 2.5%
135 (32) Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 250,337 -28.6%
136 (5) Xeloda Genentech, Inc (member of Roche group) 246,919 4.5%
137 () Toprol XL AstraZeneca Pharmaceuticals, LP 242,561 71.0%
138 (10) Maxalt Merck & Co., Inc. 240,341 9.9%
139 (20) Nasacort AQ Sanofi (formerly Sanofi Aventis) 239,549 -16.1%
140 (10) Zyvox Pfizer Inc 238,542 -4.5%
141 (54) Opana ER Endo Pharmaceuticals 235,624 51.4%
142 (24) Procrit Centocor Ortho Biotech, Inc 233,804 -18.8%
143 (12) Tussionex Sanofi (formerly Sanofi Aventis) 232,821 -5.6%
144 (87) Wellbutrin XL Valeant Pharmaceuticals International 231,227 -62.3%
145 () Exforge Novartis Corporation 228,459 53.4%
146 (10) Differin Galderma Laboratories 227,198 -5.2%
147 () Humalog Mix 75/25 Pen Eli Lilly and Company 226,135 -0.4%
148 (27) Combivir GlaxoSmithKline 225,097 -18.4%
149 (3) Vigamox Alcon Laboratories, Inc. 224,627 1.8%
150 (6) Viread Gilead Sciences, Inc. 223,915 7.9%
151 () Trilipix Abbott Laboratories 221,001 NA
152 (3) Ciprodex Otic Alcon Laboratories, Inc. 218,781 5.3%
153 (104) Actonel 150 Procter & Gamble 210,266 339.3%
154 () Maxalt MLT Merck & Co., Inc. 210,049 9.2%
155 (27) Duragesic Johnson & Johnson 209,926 -16.6%
156 (14) Asmanex Merck & Co., Inc. 206,633 11.5%
157 (6) Relpax Pfizer Inc 204,273 -4.2%
158 () Entocort EC AstraZeneca Pharmaceuticals, LP 200,489 55.0%
159 (14) BenzaClin Sanofi (formerly Sanofi Aventis) 198,107 -12.3%
160 (22) Micardis Boehringer Ingelheim Pharmaceuticals, Inc 197,550 19.0%
161 (15) Enablex Warner Chilcott 197,312 11.9%
162 (11) Micardis HCT Abbott Laboratories 197,278 9.4%
163 () Prezista Centocor Ortho Biotech, Inc 191,366 48.1%
164 (2) Revlimid Celgene Corporation 190,965 -1.8%
165 () Travatan Z Alcon Laboratories, Inc. 190,516 56.9%
166 (15) Amitiza Takeda Pharmaceuticals U.S.A., Inc 190,101 12.1%
167 (7) Alphagan P Allergan, Inc 188,803 -3.6%
168 (1) Pegasys Genentech, Inc (member of Roche group) 188,536 0.3%
169 (17) Patanol Alcon Laboratories, Inc. 187,599 -11.3%
170 () Xyzal Sanofi (formerly Sanofi Aventis) 187,542 30.0%
171 (2) Fentora Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 185,528 0.2%
172 (15) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc 184,799 -9.7%
173 (31) Clarinex Merck & Co., Inc. 181,215 -22.4%
174 (11) Avandamet GlaxoSmithKline 178,188 -7.6%
175 (38) Astelin Meda Pharmaceuticals 177,778 -25.7%
176 (8) Ultram ER Ortho-McNeil-Janssen Pharmaceuticals, Inc. 174,664 -5.7%
177 (6) Zovirax topical GlaxoSmithKline 174,423 5.7%
178 (10) Valcyte Roche Pharmaceuticals 174,413 8.6%
179 () Uroxatral 174,034 21.6%
180 () Lialda Shire US Inc 173,802 54.6%
181 (9) Temodar Merck & Co., Inc. 172,475 -5.8%
182 () Pentasa Sanofi (formerly Sanofi Aventis) 171,083 17.0%
183 (11) Allegra-D 24 Hour Sanofi (formerly Sanofi Aventis) 167,692 7.2%
184 (1) Propecia Merck & Co., Inc. 166,878 2.3%
185 () Vivelle-DOT Novartis Corporation 165,828 10.9%
186 () Zegerid Santarus, Inc. 164,756 17.7%
187 () Premarin Vaginal Pfizer Inc 164,568 10.0%
188 () Exelon Patch Novartis Corporation 162,259 74.4%
189 (9) Prempro Pfizer Inc 161,662 5.9%
190 () Prandin Novo Nordisk Inc. 161,651 10.4%
191 (156) Imitrex Oral GlaxoSmithKline 161,167 -83.4%
192 Veramyst GlaxoSmithKline 160,387 1.3%
193 (7) Taclonex Warner Chilcott 159,082 -1.6%
194 (6) Xopenex HFA Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 157,588 3.7%
195 () Duac Care System GlaxoSmithKline 155,643 9.3%
196 (7) Klor-Con Upsher-Smith Laboratories Inc. 153,842 -3.6%
197 () Epipen 153,802 18.4%
198 (5) Avinza King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 153,393 -2.4%
199 (9) Atacand AstraZeneca Pharmaceuticals, LP 152,603 -4.4%
200 () Elmiron Ortho-McNeil-Janssen Pharmaceuticals, Inc. 150,961 10.0%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web1)